In vivo, CD8+CD38high, but not CD8+CD38-, T cells ameliorated the clinical severity of murine experimental autoimmune encephalomyelitis, suggesting that CD8+CD38high T cells are potential inhibitors of excessive immune responses. This evidence concerns the gene CD8A and experimental autoimmune encephalomyelitis.